It is well known that DPP-4 promotes the pathology of diabetes via catalytic degradation of glucagon-like peptide-1 (GLP-1) and gastric inhibitory peptide (GIP), which induce postprandial secretion of insulin by pancreatic β-cells. The gene discussed is DPP4; the disease is diabetes mellitus.